The Effect of Oral Pancreatic Enzyme Supplementation on the Course and Outcome of Acute Pancreatitis: A Randomized, Double-Blind Parallel-Group Study
Context Pancreatic exocrine insufficiency is a significant problem after acute pancreatitis. Objective To evaluate whether oral pancreatic enzyme supplementation improves the recovery of pancreatic exocrine function and to explore the efficacy, safety and tolerability of pancreatic enzyme supplementation in patients during the refeeding period after acute pancreatitis. Design Prospective double-blind, placebo controlled, randomized study. Patients The sudy included 56 patients with acute pancreatitis. Main outcome measures Primary efficacy variable was recovery from pancreatic exocrine insufficiency. Secondary objectives were body weight, abdominal pain, course of APACHE II score, patient’s symptoms and quality of life. Results Twenty of the 56 patients showed low fecal elastase values indicating pancreatic exocrine insufficiency after acute pancreatitis. Median time to recovery from exocrine pancreatic insufficiency was 14 days in the enzyme supplementation group and 23 days in the placebo group but overall differences for primary and all but one secondary endpoint did not reach statistical significance. However, a positive tendency in favour of enzyme supplementation was found for quality of life parameters (FACT-Pa) in all subscores. There were no relevant differences between placebo and oral pancreatic enzyme supplementation detected with respect to safety and tolerability. Conclusion Enzyme supplementation positively effects the course of acute pancreatitis if administered during the early refeeding phase after acute pancreatitis. There is evidence that oral pancreatic enzyme supplementation has a positive impact on the course of the disease and the global health status (less weight loss, less flatulence, improved quality of life). Oral pancreatic enzyme supplementation was safely administered and can be added to the treatment regimen of patients in a refeeding status after severe acute pancreatitis.
Image: Kaplan-Meier estimates of the proportion of subjects with a response (Figure 2)
Migliori M, Pezzilli R, Tomassetti P, Gullo L. Exocrine pancreatic function after alcoholic or biliary acute pancreatitis. Pancreas. 2004;28:359-363.
Bozkurt T, Maroske D, Adler G. Exocrine pancreatic function after recovery from necrotizing pancreatitis. Hepato-Gastroenterol. 1995;42:55-58.
Glasbrenner B, Buchler MW, Uhl W, Malfertheiner P. Exocrine pancreatic function in the early recovery phase of acute oedematous pancreatitis. Eur J Gastroenterol Hepatol. 1992;4:563-567.
Gullo, L., Sarles, H., and Mott, C. B. Functional investigation of the exocrine pancreas following acute pancreatitis. Rendiconti di Gastroenterologia 1972; 4:18-21.
Mitchell CJ, Playfourth MJ, Kelleher J, McMahon MJ. Functional recovery of the exocrine pancreas after acute pancreatitis. Scand J Gastroenterol. 1983;18:5-8.
Fenton-Lee D, Imrie CW. Pancreatic necrosis: assessment of outcome related to quality of life and cost of management. Br J Surg. 1993;80:1579-1582.
Uomo G, Galluci F, Madrid E, Miraglia S, Manes G, Rabitti PG. Pancreatic functional impairment following acute necrotizing pancreatitis: long-term outcome of a non-surgically treated series. Dig Liver Dis. 2010 Feb;42(2):149-52.
Buchler MW, Hauke A, Malfertheiner P. Follow-up after acute pancreatitis: Morphology and function. In: Beger HG, Buchler MW, eds. Acute Pancreatitis. Berlin-Heidelberg: Springer-Verlag; 1987:367-74.
Tympner F, Domschke W, Rosch W, Koch H, Demling L. The function of the hydrokinetic and ekbolic pancreas after acute pancreatitis. Z Gastroenterol. 1976;14:684-687.
Symersky T, van Hoorn B, Masclee AA. The outcome of a long-term follow-up of pancreatic function after recovery from acute pancreatitis. JOP. 2006 Sep 10;7(5):447-53.
Pantakar, R. V., Chand, R., and Johnson, C. D. Pancreatic enzyme supplementation in acute pancreatitis. HPB Surg. 1995; 8(3):159-162.
Airey MC, McMahon MJ. The influence of granular pancreatin upon endocrine and exocrine function during reconvalescence from acute pancreatitis. In: Lankisch PG, ed. Pancreatic enzymes in health and disease. Springer-Verlag: Berlin-Heidelberg; 1991:129-38.
Scheefers-Borchel, U., Scheefers, H, and Arnold, R. Pancreatic elastase1: Parameter for the diagnosis of chronic and acute pancreatitis. Lab med 1992; 16:427-432.
Gullo L, Ventrucci M, Tomassetti P, Migliori M, Pezzilli R. Fecal elastase 1 determination in chronic pancreatitis. Dig Dis Sci. 1999;44:210-213.
Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med. 1985;13:818-829.
Cella DF, Tulsky DS, Gray G et al. The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol. 1993;11:570-579.
Bonomi AE, Cella DF, Hahn EA et al. Multilingual translation of the Functional Assessment of Cancer Therapy (FACT) quality of life measurement system. Qual Life Res. 1996;5:309-320.
Cella D, Butt Z, Kindler, HL, Fuchs CS, Bray S, Barlev A, Oglesby A. Validity of the FACT Hepatobiliary (FACT-Hep) questionnaire for assessing disease-related symptoms and health-related quality of life in patients with metastatic pancreatic cancer. Quality Life Res 2013 Jun; 22(5): 1105-1112.
Adler, G., Hupp, T., and Kern, H. F. Course and spontaneous regression of acute pancreatitis in the rat. Virchows Arch.A Pathol.Anat.Histol. 1979; 382:32-47.
Saluja A, Saito I, Saluja M et al. In vivo rat pancreatic acinar cell function during supramaximal stimulation with caerulein. Am J Physiol. 1985;249:G702-G710.
Niederau C, Niederau M, Luthen R, Strohmeyer G, Ferrell LD, Grendell JH. Pancreatic exocrine secretion in acute experimental pancreatitis. Gastroenterology. 1990;99:1120-1127.
Evander A, Hederstrom E, Hultberg B, Ihse I. Exocrine pancreatic secretion in acute experimental pancreatitis. Digestion. 1982;24:159-167.
Angelini G, Pederzoli P, Caliari S. Long-term outcome of acute necrohemorrhagic pancreatitis. Digestion. 1984;30:131-137.
Boreham B, Ammori BJ. A prospective evaluation of pancreatic exocrine function in patients with acute pancreatitis: correlation with extent of necrosis and pancreatic endocrine insufficiency. Pancreatology. 2003;3:303-308.
Tenner S, Sica G, Hughes M et al. Relationship of necrosis to organ failure in severe acute pancreatitis. Gastroenterology. 1997;113:899-903.
Uhl W, Buchler MW, Malfertheiner P, Martini M, Beger HG. PMN-elastase in comparison with CRP, antiproteases, and LDH as indicators of necrosis in human acute pancreatitis. Pancreas. 1991;6:253-259.
McMahon, M. J. Acute pancreatitis: when is enzyme treatment indicated? Digestion 1993; 54(2):40-42.
Dominguez-Munoz JE, Hieronymus C, Sauerbruch T, Malfertheiner P. Fecal elastase test: evaluation of a new noninvasive pancreatic function test. Am J Gastroenterol. 1995;90:834-1837.
Lankisch PG, Schmidt I, Konig H et al. Faecal elastase 1: not helpful in diagnosing chronic pancreatitis associated with mild to moderate exocrine pancreatic insufficiency. Gut. 1998;42:551-554.
Leplege A, Hunt S. The problem of quality of life in medicine. JAMA. 1997;278:47-50.
Soran A, Chelluri L, Lee KK, Tisherman SA. Outcome and quality of life of patients with acute pancreatitis requiring intensive care. J Surg Res. 2000;91:89-94.
Al Omran M, Groof A, Wilke D. Enteral versus parenteral nutrition for acute pancreatitis (Cochrane Review). Cochrane Database Syst Rev. 2003;CD002837.
Copyright (c) 2014 Stefan Kahl, Kerstin Schütte, Bernhard Glasbrenner, Julia Mayerle, Peter Simon, Friederike Henniges, Suntje Sander-Struckmeier, Marcus M Lerch, Peter Malfertheiner
This work is licensed under a Creative Commons Attribution 4.0 International License.As a member of Publisher International Linking Association, PILA, iMedPub Group’s JOP follows the Creative Commons Attribution License and Scholars Open Access publishing policies. Journal of the Pancreas is the Council Contributor Member of Council of Science Editors (CSE) and following the CSE slogan Education, Ethics, and Evidence for Editors.